radiopharmacology 

Statements about this table:
in111 - pentetreotide and in111 - octreotide be in - vivo and imaging , and have investigation of somatostatin receptor imaging
in111 - dtpa ( diethylenetriaminepenta - acetic acid ) have 2 investigation of ventriculo - peritoneal shunt (laveen shunt) and of cisternography
in - vitro / in - vivo be in - vivo for all on the list , and all be imaging , likewise
iv be the route of administration for 4 , with 1 intraperitoneal injection and 1 intra - cisternal
in111 - s leukocyte , in111 - s platelet , in111 - pentetreotide and in111 - octreotide all have intra - cisternal as the route of administration
in111 - pentetreotide and in111 - octreotide be in - vivo and imaging , and have investigation of infection / inflammation imaging
in111 - s leukocyte have 2 investigation of ventriculo - peritoneal shunt (laveen shunt) and of cisternography
iv be the route of administration for all of the radiopharmacology imaging and with no intraperitoneal injection or intra - cisternal imaging
name
investigation
route of administration
in - vitro / in - vivo
imaging / non - imaging
in111 - dtpa ( diethylenetriaminepenta - acetic acid )
ventriculo - peritoneal shunt (laveen shunt)
intraperitoneal injection
in - vivo
imaging
in111 - dtpa ( diethylenetriaminepenta - acetic acid )
cisternography
intra - cisternal
in - vivo
imaging
in111 - s leukocyte
infection / inflammation imaging
iv
in - vivo
imaging
name
investigation
route of administration
in - vitro / in - vivo
imaging / non - imaging
in111 - s platelet
thrombus imaging
iv
in - vivo
imaging
in111 - pentetreotide
somatostatin receptor imaging
iv
in - vivo
imaging
in111 - octreotide
somatostatin receptor imaging ( octreoscan )
iv
in - vivo
imaging